Suchergebnisse - "Niharika B"

1

A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors

von: Mettu, Niharika B.

2019, in: Cancer chemotherapy and pharmacology

Wird geladen...
2

Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in $ KRAS^{G12R} $-mutant pancreatic ductal adenocarcinoma

von: Kenney, Cara

2021, in: Investigational new drugs

Wird geladen...
3

Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer

von: Michael Overman

2020, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
4

Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma

von: Rigiroli, Francesca

2023, in: European radiology

Wird geladen...
5

Baseline findings of a multicentric ambispective cohort study (2021–2022) among hospitalised mucormycosis patients in India

von: Rizwan Suliankatchi Abdulkader

2024, in: Mycology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!